Skip to main content
OpenTrials

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

1,814 public trials 369 recruiting studies
Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Survey on PD Patients With Depressive Symptoms

NCT00614575

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Boehringer Ingelheim Investigational Site Akashi, Japan
  • Boehringer Ingelheim Investigational Site 1 Akita, Japan
  • Boehringer Ingelheim Investigational Site 2 Akita, Japan
  • Boehringer Ingelheim Investigational Site Asahikawa, Japan
View all 238 locations
View Trial Details
Completed

A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period

NCT00560508

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.610.019 Boehringer Ingelheim Investigational Site Akashi, Hyogo, Japan
  • 248.610.020 Boehringer Ingelheim Investigational Site Akita, Akita, Japan
  • 248.610.006 Boehringer Ingelheim Investigational Site Aomori, Aomori, Japan
  • 248.610.017 Boehringer Ingelheim Investigational Site Asahikawa, Hokkaido, Japan
View all 19 locations
View Trial Details
Completed

Pivotal Study in Advanced Parkinsons Disease Patients

NCT00466167

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.525.43005 Boehringer Ingelheim Investigational Site Linz, Austria
  • 248.525.42003 Boehringer Ingelheim Investigational Site Pardubice, Czechia
  • 248.525.42001 Boehringer Ingelheim Investigational Site Prague, Czechia
  • 248.525.42005 Boehringer Ingelheim Investigational Site Rakovník, Czechia
View all 76 locations
View Trial Details
Completed

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

NCT00297778

Conditions
Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +9 more
Locations
  • 248.596.43003 Boehringer Ingelheim Investigational Site Graz, Austria
  • 248.596.43001 Boehringer Ingelheim Investigational Site Innsbruck, Austria
  • 248.596.43005 Boehringer Ingelheim Investigational Site Linz, Austria
  • 248.596.43004 Boehringer Ingelheim Investigational Site Sankt Pölten, Austria
View all 77 locations
View Trial Details
Completed

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • 248.633.01004 Boehringer Ingelheim Investigational Site Sun City, Arizona, United States
  • 248.633.01018 Boehringer Ingelheim Investigational Site Tempe, Arizona, United States
  • 248.633.01016 Boehringer Ingelheim Investigational Site La Jolla, California, United States
  • 248.633.01013 Boehringer Ingelheim Investigational Site Oxnard, California, United States
View all 119 locations
View Trial Details

Related conditions